Cytomegalovirus (CMV)-specific cellular immune responses

被引:80
|
作者
Harari, A [1 ]
Zimmerli, SC [1 ]
Pantaleo, G [1 ]
机构
[1] Univ Lausanne, CHU Vaudois, Div Immunol & Allergy, Lab AIDS Immunopathogenesis, CH-1011 Lausanne, Switzerland
关键词
CMV; immune response; T cells; HIV; monitoring;
D O I
10.1016/j.humimm.2004.02.012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A large percentage of healthy individuals (50-9%) is chronically infected with Cytomegalovirus (CMV). Over the past few years, several techniques were developed in order to monitor CMV-specific T-cell responses. In addition to the identification of antigen-specific T cells with peptide-loaded MHC complexes, most of the current strategies to identify CMV-specific T cells are centered on the assessment of the functions of memory T cells including their ability to mediate effector function, to proliferate or to secrete cytokines following antigen-specific stimulation. The investigation of these functions has allowed the characterization of the CMV-specific T-cell responses that are present during different phases of the infection. Furthermore, it has also been shown that the combination of virus-specific CD4 and CD8 T-cell responses are critical components of the immune response in the control of virus replication. Human Immunology 65, 500-506 (2004). (C) American Society for Histocompatibility and Immunogenetics, 2004. Published by Elsevier Inc.
引用
收藏
页码:500 / 506
页数:7
相关论文
共 50 条
  • [21] Cytomegalovirus (CMV)-Specific T Cells as a Parameter for Individual CMV-Specific Immune Response after Pediatric Kidney Transplantation (Tx)
    Ahlenstiel, T.
    Sester, U.
    Sester, M.
    Pape, L.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1810 - 1810
  • [22] IMMUNE-RESPONSES TO FRACTIONATED CYTOMEGALOVIRUS (CMV) ANTIGENS AFTER HIV-INFECTION - LOSS OF CELLULAR AND HUMORAL REACTIVITY TO ANTIGENS RECOGNIZED BY HIV-, CMV+ INDIVIDUALS
    CONVERSE, PJ
    FEHNIGER, TE
    EHRNST, A
    STRANNEGARD, O
    BRITTON, S
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 82 (03): : 559 - 566
  • [23] Aging, cytomegalovirus (CMV) and influenza vaccine responses
    Frasca, Daniela
    Blomberg, Bonnie B.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (03) : 682 - 690
  • [24] MONITORING CELLULAR IMMUNE RESPONSES TO CMV TO GUIDE THERAPY OF CMV DISEASE IN PEDIATRIC RENAL TRANSPLANT (Tx) RECIPIENTS
    Puliyanda, Dechu P.
    Ge, Shili
    Karasyov, Artur
    Jordan, Stanley C.
    Kamil, Elaine S.
    Toyoda, Mieko
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 104 - 104
  • [25] Peptide vaccination against cytomegalovirus (CMV) elicits both cellular and humoral immune responses clearing the virus load after allogeneic stem cell transplantation from a CMV seronegative donor
    Michael, S.
    Schmitt, A.
    Wiesneth, M.
    Hueckelhoven, A.
    Wu, Z.
    Kuball, J.
    Wang, L.
    Schauwecker, P.
    Hofmann, S.
    Goetz, M.
    Maccari, B.
    Michels, B.
    Wuchter, P.
    Mertens, T.
    Schnitzler, P.
    Doehner, H.
    Ho, A.
    Bunjes, D.
    Dreger, P.
    Schrezenmeier, H.
    Greiner, J.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S33 - S33
  • [26] ASSESSMENT OF CYTOMEGALOVIRUS (CMV) SPECIFIC AND OVERALL IMMUNE RESPONSE IN LUNG TRANSPLANT PATIENTS WITH POSITIVE CMV SEROLOGY PRE-TRANSPLANTATION
    Sintes, Helena
    Monforte, Victor
    Ussetti, Piedad
    Perez, Virginia
    Redel, Javier
    Sole, Amparo
    Maria Borro, Jose
    Cifrian, Jose
    TRANSPLANT INTERNATIONAL, 2017, 30 : 327 - 328
  • [27] CYTOMEGALOVIRUS (CMV) ANTIBODY IN MALE-HOMOSEXUALS - A SOURCE FOR CMV IMMUNE GLOBULIN
    IKRAM, H
    PRINCE, AM
    BAKER, LN
    VOX SANGUINIS, 1983, 44 (03) : 173 - 177
  • [28] Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients
    Jacobson, MA
    Sinclair, E
    Bredt, B
    Agrillo, L
    Black, D
    Epling, CL
    Carvidi, A
    Ho, T
    Bains, R
    Adler, SP
    JOURNAL OF CLINICAL VIROLOGY, 2006, 35 (03) : 332 - 337
  • [29] CYTOMEGALOVIRUS-SPECIFIC IMMUNE-RESPONSE AND THE CELLULAR IMMUNE STATUS OF MALIGNANT-LYMPHOMA
    TENNAPEL, CHH
    VANEGTENBIJKER, J
    HALIE, MR
    LANGENHUYSEN, MMAC
    THE, TH
    JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1980, 4 (03) : 145 - 151
  • [30] CMV-SPECIFIC IMMUNE-RESPONSES AND HLA PHENOTYPES OF AIDS PATIENTS WHO DEVELOP CMV RETINITIS
    SCHRIER, RD
    FREEMAN, WR
    WILEY, CA
    MCCUTCHAN, JA
    ADVANCES IN NEUROIMMUNOLOGY, 1994, 4 (03): : 327 - 336